Your ANSwer for Workers' Compensation Medical Cost Containment

Call Us Today!|info@ans-solutions.com

Chronic Pain Treatment: Impacts of Drug-Drug Interactions

Polypharmacy, the use of 4 or more medications simultaneously, is a dangerous but frequent practice for chronic pain patients. Unfortunately, because many patients undergoing chronic pain treatment suffer multiple chronic health issues, exposure to drug-drug interactions (DDI) is a common but unintended result, leading to severe consequences for the physical health of patients, as well as a significantly increased financial burden for all involved: patients, providers, and society.

What defines a drug-drug interaction?

A pharmacokinetic DDI involves two or more drugs interacting in such a way that the effectiveness and/or toxicity […]

By |December 15th, 2015|Drug Utilization Review, Pharmacotherapy Review|Comments Off on Chronic Pain Treatment: Impacts of Drug-Drug Interactions

No Proven Benefit for the Use of Opioids in Chronic Pain

ANS provides Drug Utilization Review for large loss workers comp claimsMillions are addicted to or dependent on prescription opioids. Worse than the dependency, over 200,000 deaths are attributable to prescription opioids, as well as hundreds of thousands of overdoses. What’s the biggest contributor to the epidemic, you ask? Most commonly, it’s the inappropriate prescription of opioids for the treatment of issues like musculoskeletal disorders, chronic low back pain, headaches, and other issues.

Insights from a Leading Pain Expert

A recent study conducted by […]

By |October 15th, 2015|Drug Utilization Review, Opioid Abuse, Pharmacotherapy Review|Comments Off on No Proven Benefit for the Use of Opioids in Chronic Pain

What Role does the Doctor-Patient Relationship Play in the Opioid Epidemic?

According to the DEA, sales of prescription painkillers in the United States have quadrupled since 1999. If that isn’t enough to raise eyebrows, consider the following: almost twice as many people abuse prescription drugs as the number of people abusing cocaine, heroin, hallucinogens and inhalants combined. And if that’s that enough, the U.S. Center for Disease Control and Prevention has stated that prescription drug overdose death rates in the United States have more than tripled since 1990 and have never been higher. These statistics have raised serious concerns, triggering […]

By |September 30th, 2015|Drug Utilization Review, Medical Cost Containment, Opioid Abuse, Pharmaceutical Cost Containment, Pharmacotherapy Review|Comments Off on What Role does the Doctor-Patient Relationship Play in the Opioid Epidemic?

High Risk Patient Profiles & Opioid Abuse

Drug Utilization Review and Medical Cost Containment StrategiesPredictive models in our industry show that specific risk factors correlate to the potential for long term opioid use -most notably, patients that smoke and/or have a history of substance abuse.   With increased opioid prescribing linked to trends of misuse and abuse and opioid related overdoses contributing to more deaths annually than vehicular crashes, it begs the question, are risk factors truly being taken into account with the treatment of chronic pain?

Improving […]

By |September 15th, 2015|Drug Utilization Review, Medical Cost Containment, Pharmacotherapy Review|Comments Off on High Risk Patient Profiles & Opioid Abuse

Ineffective Intervention Results in Less Than Optimal Outcomes

Workers’ compensation payers industry-wide have relied on pharmaceutical cost containment measures in one form or another as a means to manage escalating costs. But as everyone has learned, not all strategies are created equal. In fact, most are limited in scope and effectiveness.Holistic Drug Utilization Review

A Holistic Approach to Medical Cost Management

At ANS, we take a holistic, collaborative approach to managing medical costs. When a comprehensive analysis is conducted on a pharmaceutical regimen, it reveals the bigger picture, thus uncovering […]

By |August 30th, 2015|Drug Utilization Review, Medical Cost Containment, Pharmacotherapy Review|Comments Off on Ineffective Intervention Results in Less Than Optimal Outcomes

The Perfect Storm: Rising Pharma Costs & Part D

Medicare Set Aside - ANS medical cost containment help bring all the pieces togetherAs we all know, injured worker treatment regimens relying heavily on costly prescriptions is the unfortunate norm. On top of that, pharma costs are continually rising, surpassing general and medical cost inflation. It seems that Payers can’t catch a break. To add insult to injury, Medicare Part D came into existence as part of the Medicare Modernization Act, which further mandated the inclusion of prescription drug coverage in […]

By |July 15th, 2015|Drug Utilization Review, Medicare Set Aside, Part D|Comments Off on The Perfect Storm: Rising Pharma Costs & Part D

The Human Side of Medical Cost Management

ANS Medical Cost Management - the Human Side of medical cost containment through drug utilization reviewWhen we talk about the costly nature of large loss Workers’ Comp claims, it is sometimes hard to think beyond the financial impact. Further to this point, when medical cost containment strategies are discussed they are often geared toward addressing the clinical and pharmaceutical treatment programs for injured workers from a financial perspective. What about the less tangible side of medical cost containment-the human costs which […]

By |June 15th, 2015|Drug Utilization Review, Medical Cost Containment, Pharmaceutical Industry|Comments Off on The Human Side of Medical Cost Management

Pharmaceutical Review- Breaking the Cost Cycle for Payers

pharmacotherapy review Prescription drug abuse is a nationwide epidemic with the Workers’ Compensation industry experiencing significant collateral damage. The trending use of opioid analgesics for chronic pain treatment of injured workers, coupled with the high potential for dependency or abuse of opioids not only contributes to skyrocketing costs for the payer, but also poses increased risks for the injured worker. So where can Payers turn to break the pharmaceutical cost cycle?

A Drug Utilization Review That Actually Works

Many pharmaceutical cost containment […]

By |March 30th, 2015|Drug Utilization Review, Workers Compensation Payers|Comments Off on Pharmaceutical Review- Breaking the Cost Cycle for Payers

What Is A Medical Cost Projection Analysis?

Medical Cost ProjectionMedical Cost Containment Solutions By ANS (MCP) is a medical cost containment analysis often used to set reserves in complex cases where multiple factors drive exposure, and complex medical and legal information needs to be considered. Most people look at it as “what this case is worth,” but that’s not really accurate. MCP, when done right, is a comprehensive and expert analysis which generates reliable, evidence-based recommendations to positively manage the medical portion of a large […]

By |March 14th, 2015|Drug Utilization Review, Medical Cost Projection|Comments Off on What Is A Medical Cost Projection Analysis?